Vertical Sleeve Gastrectomy Restores Glucose Homeostasis in Apolipoprotein A-IV KO Mice

Autor: Joyce Sorrell, Patrick Tso, April Haller, Darleen A. Sandoval, Josh W. Pressler, Randy J. Seeley, Fei Wang
Rok vydání: 2014
Předmět:
Blood Glucose
medicine.medical_specialty
Sleeve gastrectomy
Apolipoprotein B
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
030209 endocrinology & metabolism
Apolipoprotein A-IV
Carbohydrate metabolism
Mice
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Gastrectomy
Internal medicine
Dietary Carbohydrates
polycyclic compounds
Internal Medicine
medicine
Animals
Homeostasis
Glucose homeostasis
RNA
Messenger

Apolipoproteins A
030304 developmental biology
Mice
Knockout

0303 health sciences
Triglyceride
biology
Body Weight
nutritional and metabolic diseases
Dietary Fats
3. Good health
Mice
Inbred C57BL

Glucose
Endocrinology
Gene Expression Regulation
chemistry
biology.protein
lipids (amino acids
peptides
and proteins)

Dietary Proteins
Obesity Studies
Zdroj: Diabetes
ISSN: 1939-327X
0012-1797
DOI: 10.2337/db14-0825
Popis: Bariatric surgery is the most successful strategy for treating obesity, yet the mechanisms for this success are not clearly understood. Clinical literature suggests that plasma levels of apolipoprotein A-IV (apoA-IV) rise with Roux-en-Y gastric bypass (RYGB). apoA-IV is secreted from the intestine postprandially and has demonstrated benefits for both glucose and lipid homeostasis. Because of the parallels in the metabolic improvements seen with surgery and the rise in apoA-IV levels, we hypothesized that apoA-IV was necessary for obtaining the metabolic benefits of bariatric surgery. To test this hypothesis, we performed vertical sleeve gastrectomy (VSG), a surgery with clinical efficacy very similar to that for RYGB, in whole-body apoA-IV knockout (KO) mice. We found that VSG reduced body mass and improved both glucose and lipid homeostasis similarly in wild-type mice compared with apoA-IV KO mice. In fact, VSG normalized the impairment in glucose tolerance and caused a significantly greater improvement in hepatic triglyceride storage in the apoA-IV KO mice. Last, independent of surgery, apoA-IV KO mice had a significantly reduced preference for a high-fat diet. Altogether, these data suggest that apoA-IV is not necessary for the metabolic improvements shown with VSG, but also suggest an interesting role for apoA-IV in regulating macronutrient preference and hepatic triglyceride levels. Future studies are necessary to determine whether this is the case for RYGB as well.
Databáze: OpenAIRE